Home › Industries › Research and Development in Biotechnology
Recompete pipeline in Research and Development in Biotechnology
NAICS 541711
$2.7BCeiling value on the cliff
5Contracts expiring ≤ 18 mo
Federal contracts classified under NAICS 541711 (Research and Development in Biotechnology) that reach the end of their current period of performance within 18 months, sorted soonest first.
| Incumbent | Agency | Ceiling value | Ends | Expiry |
|---|---|---|---|---|
| EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
HHSO100201600030C |
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $1,409,725,727 | 2026-09-29 | in 1 month |
| DYNPORT VACCINE COMPANY LLC
W911QY13C0056 |
Department of Defense Department of the Army | $117,632,941 | 2027-03-11 | in 7 months |
| REGENERON PHARMACEUTICALS INC
HHSO100201700016C |
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $695,741,476 | 2027-09-29 | in 13 months |
| REGENERON PHARMACEUTICALS INC
HHSO100201700020C |
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $279,610,568 | 2027-09-24 | in 13 months |
| MERCK SHARP & DOHME LLC
HHSO100201700012C |
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | $236,307,634 | 2027-09-27 | in 13 months |
"Expiring" is the current period-of-performance end date recorded on USAspending.gov (U.S. Treasury); it signals a
likely recompete but does not guarantee one. See the method.